Boston scientific corporation (BSX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Sep'08Jun'08
Net sales

10,785

10,735

10,392

10,078

9,937

9,823

9,671

9,500

9,267

9,048

8,830

8,713

8,582

8,386

8,173

7,956

7,673

7,477

7,386

7,344

7,374

7,380

7,331

7,220

7,156

7,143

7,125

7,125

7,144

7,249

7,277

7,416

7,563

7,622

7,776

7,818

7,771

7,806

7,883

7,992

8,138

8,188

8,087

8,086

0

0

0

Cost of products sold

3,192

3,116

2,995

2,890

2,871

2,813

2,757

2,722

2,615

2,593

2,537

2,494

2,501

2,424

2,380

2,325

2,226

2,173

2,159

2,170

2,193

2,210

2,206

2,166

2,133

2,174

2,200

2,248

2,296

2,349

2,427

2,549

2,659

2,659

2,658

2,601

2,567

2,599

2,650

2,656

2,632

2,576

2,521

2,496

0

0

0

Gross profit

7,594

7,620

7,399

7,189

7,067

7,011

6,913

6,778

6,652

6,455

6,293

6,219

6,081

5,962

5,793

5,631

5,447

5,304

5,227

5,174

5,181

5,170

5,125

5,054

5,023

4,969

4,925

4,877

4,848

4,900

4,850

4,867

4,904

4,963

5,118

5,217

5,204

5,207

5,233

5,336

5,506

5,612

5,566

5,590

0

0

0

Operating expenses:
Selling, general and administrative expenses

4,050

3,941

3,802

3,660

3,578

3,569

3,501

3,431

3,360

3,294

3,241

3,213

3,177

3,099

3,043

3,000

2,921

2,873

2,849

2,861

2,904

2,902

2,874

2,791

2,709

2,674

2,589

2,520

2,507

2,535

2,516

2,556

2,550

2,487

2,551

2,556

2,548

2,580

2,544

2,575

2,612

2,635

2,597

2,587

0

0

0

Research and development expenses

1,194

1,174

1,154

1,137

1,132

1,113

1,089

1,054

1,023

997

989

967

945

920

907

896

894

876

841

832

818

817

826

831

848

861

882

885

875

886

879

888

898

895

888

889

898

939

972

1,000

1,031

1,035

1,030

1,025

0

0

0

Royalty expense

61

65

66

68

68

70

70

69

69

68

70

74

77

79

77

74

72

70

77

81

88

111

110

117

139

140

144

145

146

153

158

165

169

172

177

180

185

185

188

200

196

191

201

198

0

0

0

Loss on program termination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

Amortization expense

740

699

662

632

618

599

577

568

563

565

562

559

552

545

542

537

518

495

471

449

442

438

432

424

416

410

405

403

401

395

391

389

386

421

457

489

517

513

512

509

511

511

511

520

0

0

0

Goodwill impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

423

423

1,171

4,773

4,350

4,350

3,602

0

697

697

697

666

1,817

0

0

0

-

-

-

-

-

-

Intangible asset impairment charges

236

105

104

104

101

35

36

39

5

4

10

0

0

-

0

-

-

-

0

0

-

195

177

165

108

53

66

195

0

-

0

0

-

-

0

0

-

65

75

0

0

-

-

0

-

0

0

Contingent consideration expense (benefit)

-115

-35

-19

-40

-54

-21

-14

-5

-25

-80

-73

-82

-25

29

61

114

100

123

123

79

-36

-85

-136

-109

5

4

21

-22

-39

-6

-21

5

11

7

19

13

0

-

0

0

-

-

-

-

-

-

-

Purchased research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

Acquisition-related milestone

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

0

0

0

-

-

-

-

0

-

Restructuring charges (credits)

42

38

25

25

29

36

41

50

46

37

23

16

29

28

32

34

23

26

48

43

55

69

83

100

111

101

99

134

136

136

103

71

61

89

97

80

89

116

115

119

105

63

65

66

0

0

0

Litigation-related net charges (credits)

263

115

-23

-30

-45

103

107

77

282

285

368

384

797

804

1,088

1,541

922

1,105

1,286

968

1,236

1,036

414

351

84

221

279

253

322

192

119

69

0

-

0

0

-

-

-

-

-

2,022

857

621

0

0

0

Gain on divestiture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

10

10

44

38

44

55

21

15

21

18

18

778

768

760

0

-

0

0

-

-

-

-

-

0

0

Operating expenses

6,471

6,102

5,770

5,556

5,426

5,504

5,408

5,283

5,324

5,170

5,187

5,142

5,563

5,515

5,713

6,198

5,461

5,587

5,776

5,360

5,655

5,471

4,806

4,696

4,376

4,849

4,815

5,464

9,242

8,768

8,664

7,913

4,126

4,059

4,037

4,059

4,052

5,863

7,468

7,771

7,897

6,506

5,201

4,973

0

0

0

Operating income (loss)

1,123

1,518

1,627

1,632

1,640

1,506

1,506

1,495

1,328

1,285

1,106

1,077

518

447

80

-567

-14

-283

-549

-186

-474

-301

319

358

647

120

110

-587

-4,394

-3,868

-3,814

-3,046

778

904

1,081

1,158

1,152

-656

-2,235

-2,435

-2,391

-894

365

617

0

0

0

Other income (expense):
Interest expense

452

473

358

321

289

241

233

232

233

229

229

230

231

233

236

236

283

284

279

275

222

216

218

301

313

324

330

258

257

261

269

266

275

281

316

345

375

393

409

409

398

407

397

424

0

0

0

Other, net

-419

-358

-281

42

204

156

80

-57

-145

-124

-83

-105

-33

-37

-93

-70

-74

-83

-39

-36

-10

8

3

4

-17

-19

-11

-9

27

22

25

28

-11

19

7

11

8

-14

4

-3

3

-7

3

-78

0

0

0

Income (loss) before income taxes

252

687

989

1,354

1,556

1,422

1,354

1,207

951

933

794

742

254

177

-249

-873

-371

-650

-867

-497

-706

-509

104

61

317

-223

-231

-854

-4,624

-4,107

-4,058

-3,284

492

642

772

824

785

-1,063

-2,640

-2,847

-2,786

-1,308

-29

115

0

0

0

Income tax expense (benefit)

-4,034

-4,013

-101

-42

-242

-249

683

685

839

828

-49

-46

-181

-170

-330

-528

-335

-411

-471

-342

-453

-390

-184

-179

-49

-102

-63

-27

-89

-39

-36

-68

-16

201

202

206

215

2

-263

-186

-185

-283

-18

-66

0

0

0

Net income (loss)

4,287

4,700

1,090

1,396

1,797

1,671

670

521

112

104

843

788

435

347

81

-345

-36

-239

-396

-155

-253

-119

288

240

366

-121

-168

-827

-4,535

-4,068

-4,022

-3,216

508

441

570

618

570

-1,065

-2,377

-2,661

-2,601

-1,025

-11

181

0

0

0

Net income (loss) per common share — basic

0.01

2.87

0.09

0.11

0.31

0.28

0.31

0.40

0.22

-0.45

0.21

0.11

0.21

0.09

0.17

-0.15

0.15

-0.11

-0.15

0.08

0.00

-0.22

0.03

0.00

0.10

0.07

0.00

0.10

-0.26

0.02

-0.48

-2.51

0.08

0.07

0.09

0.10

0.03

0.16

0.13

0.06

-1.05

-0.71

-0.06

0.10

-0.01

-0.04

0.07

Net income (loss) per common share — assuming dilution

0.01

2.83

0.09

0.11

0.30

0.27

0.31

0.40

0.21

-0.44

0.20

0.11

0.21

0.08

0.17

-0.15

0.15

-0.11

-0.15

0.08

0.00

-0.22

0.03

0.00

0.10

0.07

0.00

0.10

-0.26

0.02

-0.48

-2.51

0.08

0.07

0.09

0.10

0.03

0.17

0.12

0.06

-1.05

-0.71

-0.06

0.10

-0.01

-0.04

0.07

Pension termination charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

44

8

8

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares outstanding
Basic

1,397

1,394

1,393

1,391

1,387

1,384

1,382

1,380

1,376

1,373

1,372

1,369

1,365

1,362

1,360

1,357

1,350

1,345

1,344

1,341

1,333

1,326

1,325

1,323

1,321

1,329

1,340

1,343

1,351

1,365

1,392

1,423

1,445

1,467

1,514

1,528

1,526

1,520

1,519

1,516

1,514

1,510

1,509

1,506

1,504

1,500

1,497

Assuming dilution

1,413

1,413

1,412

1,408

1,408

1,406

1,403

1,398

1,396

1,395

1,394

1,391

1,390

1,401

1,379

1,357

1,369

1,325

1,344

1,361

1,333

1,255

1,347

1,345

1,349

1,314

1,340

1,358

1,351

1,357

1,392

1,423

1,454

1,479

1,524

1,535

1,536

1,502

1,529

1,525

1,514

1,503

1,509

1,514

1,504

1,500

1,505